AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

US pharmaceutical giant Pfizer's new research and development (R&D) centre officially opened at BioPark in the Beijing Economic-Technological ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...

Against the backdrop of geopolitical tensions and growing waves of trade protectionism, foreign enterprises are doubling ...

As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...

China's president Xi Jinping recently held a meeting with 40 leaders of multinational companies, including BMW and ...

China's president Xi Jinping recently held a meeting with 40 leaders of multinational companies, including BMW and ...

The pharmaceutical firm expects its workforce in Beijing to grow to 1,700 employees and is launching a JV with BioKangtai to ...

They include Rajesh Subramaniam of FedEx, Bill Winters of Standard Chartered, Paul Hudson of Sanofi, and Pascal Soriot of ...

Xi said all this shows that China offers a vast stage for business development, vast market prospects, stable policy outlook, and a secure environment, making it a favored choice for foreign ...